News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Lower levels of cancer aneuploidy were associated with more favourable outcomes after immune checkpoint inhibition…
Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack…
A combination of copanlisib and rituximab led to a 48 percent reduction in the risk…
Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of…
Compared with available standard therapies, including immune checkpoint inhibitors, treatment with the bispecific fusion protein…
Peter Mac researchers feature in this week’s American Association of Cancer Research program, which is…
Immunotherapy together with an experimental cancer drug could offer a new way of treating some…
On the surface, Parkinson’s disease — a neurodegenerative disorder — and melanoma — a type…
Clinical activity with a second drug inhibiting KRASG12C confirms its role as a therapeutic target…
Exposure in the womb to a drug used to prevent miscarriage appears to raise the…